相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles
Nishtha Panwar et al.
NANOTECHNOLOGY (2015)
Biodegradable nanoparticle-mediated K-ras down regulation for pancreatic cancer gene therapy
Chengbin Yang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Discovery of siRNA Lipid Nanoparticles to Transfect Suspension Leukemia Cells and Provide In Vivo Delivery Capability
Wei He et al.
MOLECULAR THERAPY (2014)
A Paradigm Change: Efficient Transfection of Human Leukemia Cells by Stimuli-Responsive Multicompartment Micelles
Alexandra C. Rinkenauer et al.
ACS NANO (2013)
Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation
Juliana Valencia-Serna et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Synthesis of Cationic Polylactides with Tunable Charge Densities as Nanocarriers for Effective Gene Delivery
Charles H. Jones et al.
MOLECULAR PHARMACEUTICS (2013)
Synthetic Gene Transfer Vectors II: Back to the Future
Jean-Paul Behr
ACCOUNTS OF CHEMICAL RESEARCH (2012)
Lipopolysaccharide enhances FcεRI-mediated mast cell degranulation by increasing Ca2+ entry through store-operated Ca2+ channels: implications for lipopolysaccharide exacerbating allergic asthma
Chengbin Yang et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Nanowire-Mediated Delivery Enables Functional Interrogation of Primary Immune Cells: Application to the Analysis of Chronic Lymphocytic Leukemia
Alex K. Shalek et al.
NANO LETTERS (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Well-Defined Degradable Cationic Polylactide as Nanocarrier for the Delivery of siRNA to Silence Angiogenesis in Prostate Cancer
Chih-Kuang Chen et al.
ADVANCED HEALTHCARE MATERIALS (2012)
Cancer nanotechnology: application of nanotechnology in cancer therapy
Ranjita Misra et al.
DRUG DISCOVERY TODAY (2010)
Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr-abl fusion gene in Chronic Myeloid Leukemia cells
Yamini Arthanari et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nonviral Vectors for Gene Delivery
Meredith A. Mintzer et al.
CHEMICAL REVIEWS (2009)
Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein
Akiko Eguchi et al.
NATURE BIOTECHNOLOGY (2009)
Cationic lipids and polymers mediated vectors for delivery of siRNA
Shubiao Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Effective treatment of leukemic cell lines with wt1 siRNA
W. Glienke et al.
LEUKEMIA (2007)
Targeting of gene expression by siRNA in CML primary cells
Michaela Merkerova et al.
MOLECULAR BIOLOGY REPORTS (2007)
Prospects of RNA interference therapy for cancer
SI Pai et al.
GENE THERAPY (2006)
Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation
J Rangatia et al.
LEUKEMIA (2006)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
All common p210 and p190 Bcr-abl variants can be targeted by RNA interference
L Wohlbold et al.
LEUKEMIA (2005)
Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs -: Cross-talk with cell proliferation factors and other oncogenes
H Ohba et al.
CANCER (2004)
Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors
P Ramaraj et al.
CANCER RESEARCH (2004)
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
M Azam et al.
CELL (2003)
Dietary glycine inhibits angiogenesis during wound healing and tumor growth
K Amin et al.
CANCER BIOLOGY & THERAPY (2003)
Molecular and chromosomal mechanisms of resistance to imatinib (ST1571) therapy
A Hochhaus et al.
LEUKEMIA (2002)
Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi)
M Wilda et al.
ONCOGENE (2002)
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
S Branford et al.
BLOOD (2002)
BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571:: a prospective study
N von Bubnoff et al.
LANCET (2002)
A model of human p210bcr/ABL-mediated chronic myelogenous leukemia by transduction of primary normal human CD34+ cells with a BCR/ABL-containing retroviral vector
RC Zhao et al.
BLOOD (2001)
分享论文
